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ScienceDirectMembrane protein structural biology is critically dependent
upon the supply of high-quality protein. Over the last few years,
the value of crystallising biochemically characterised,
recombinant targets that incorporate stabilising mutations has
been established. Nonetheless, obtaining sufficient yields of
many recombinant membrane proteins is still a major
challenge. Solutions are now emerging based on an improved
understanding of recombinant host cells; as a ‘cell factory’
each cell is tasked with managing limited resources to
simultaneously balance its own growth demands with those
imposed by an expression plasmid. This review examines
emerging insights into the role of translation and protein folding
in defining high-yielding recombinant membrane protein
production in a range of host cells.
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Recombinant proteins are essential to
progress in modern structural biology
Progress in soluble protein structural biology continues
at a ‘breathless pace’ [1], while success in the membrane
protein field lags behind [2]. However, recent advances
in experimental approaches [3] mean that even the most
recalcitrant membrane proteins are now tenable struc-
tural biology targets; this requires sufficient, stable
recombinant protein for biochemical characterisation
and crystallisation trials. A widely used strategy is illus-
trated in Figure 1, where the chosen host cell is regarded
as a ‘cell factory’ that can be used to produce the target
protein. This typically necessitates mutagenesis of the
expression construct to increase protein yield [4] pluswww.sciencedirect.com the incorporation of additional mutations to stabilise the
resultant protein so it is more likely to crystallise [3].
These manipulations can be done pre-translationally by
mutating the gene sequence (e.g. [5]) or fusing it with a
stabilising partner (e.g. [6]). Alternatively, the protein
can be engineered post-translationally by deglycosyla-
tion, proteolysis or by making other chemical modifica-
tions [7]. The 3 A˚ crystal structure of the GABAA
receptor (Figure 2) was solved after approximately
one-hundred construct variants of the full-length human
b3 subunit were evaluated (in a stable mammalian cell-
line [8]); the consequences were examined of N-linked
glycosylation site removal, mutation of cysteine resi-
dues, amino-terminal and carboxy-terminal truncations,
truncations in the intracellular loop connecting trans-
membrane helices 3 and 4 and introduction of T4
lysozyme to minimise loop flexibility [9]. The structure
of the TRPV1 channel at 3.4 A˚ was possible because
recent developments in electron cryo-microscopy meant
that absolute conformational homogeneity was not re-
quired and only small amounts of protein were needed;
consequently a less extensive mutational strategy was
necessary [10]. Even in this case, however, the recom-
binant TRPV1 variant (produced using a modified
baculovirus system) was composed of amino acids
110–603 and 627–764, demonstrating the importance
of prior biochemical characterisation [10]. Similar meth-
odological approaches have been used for proteins
produced in Escherichia coli [e.g. 11], Saccharomyces cer-
evisiae [e.g. 12] and Pichia pastoris [e.g. 13] (see also
Figure 2, Table 1).
Understanding the host cell provides new
opportunities to improve functional yields
A complementary, host–cell-centric approach to produc-
ing recombinant proteins for structural analysis focuses on
maximising the functional yield of every cell; in this case,
the philosophy is to understand the workings of the ‘cell
factory’ (Figure 3). Any recombinant host cell must si-
multaneously balance its requirements for cellular growth
with the metabolic burden imposed by the expression
plasmid. Consequently, if it were possible to uncouple
growth from recombinant synthesis in a host cell that
remained metabolically capable of transcription and trans-
lation, this might enable metabolic fluxes to be entirely
diverted to the production of a recombinant protein [14].
This concept has been demonstrated in E. coli to produce
soluble chloramphenicol acetyltransferase to more thanCurrent Opinion in Structural Biology 2015, 32:147–155
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Recombinant protein production for structural biology. Heterologous DNA is introduced into a host cell with the aim of producing a recombinant
protein. This typically necessitates mutagenesis of the expression construct to increase protein yield plus the incorporation of additional mutations
to stabilise the resultant protein so it is more likely to crystallise. These manipulations can be done pre-translationally by mutating the gene
sequence or fusing it with a stabilising partner. Alternatively, the protein can be engineered post-translationally. In many cases, many tens or even
hundreds of constructs are examined before proceeding to structural studies.40% of total cell protein [15], but has not been widely
adopted by structural biologists. A concept that has gained
more traction focuses on the idea that the modulation of
translation and protein folding may help to further
improve host cells [16]. This review examines emerging
insights into the role of these dependent pathways in
defining high-yielding recombinant membrane protein
production experiments.
Post-transcriptional bottlenecks in
recombinant protein production
Many commonly used recombinant expression systems
(Table 1) use strong promoters to drive high rates of
mRNA synthesis (although this may be countered by high
rates of mRNA degradation [17]). In the E. coli Walker
strains C41(DE3) and C43(DE3) [18], acquired mutations
were found to lower the efficiency of the T7 promoter
leading to improved yields of membrane proteins for
some but not all targets [19]. Similarly, in the E. coli
MemStar system, the activity of T7 RNA polymerase wasCurrent Opinion in Structural Biology 2015, 32:147–155 found to be modulated [20]. In a separate study, a series of
evolved E. coli strains that had been selected based on
their resistance to erythromycin were found to have a
mutation in the hns gene, which has a role in transcrip-
tional silencing [21]. These examples suggest that a
common theme of prokaryotic strains selected for their
high-yielding properties is a tendency to rebalance
mRNA and protein synthesis rates, although the detail
of how this is achieved is not yet understood.
A recent analysis of functional yields (by radioligand
binding) and total yields (by immunoblotting) of recom-
binant angiotensin II type 1 receptor produced in insect
cells showed that the majority of the protein was non-
functional. When the same protein was produced in a
stable, inducible HEK293 cell-line that had been select-
ed by fluorescence-activated cell sorting to identify a
high-yielding clone, a similar total yield was obtained,
but the majority of the protein was now functional [22].
Several factors may account for this observation: first, thewww.sciencedirect.com
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Figure 2
(a) KcsA potassium channel; Escherichia coli (b) Aquaporin 2; Pichia pastoris (c) NRT1.1 transporter; Saccharomyces cerevisiae
(e) GABAA receptor; mammalian cells(d) Voltage-gated calcium channel; baculovirus system 
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Examples of recent structures of recombinant membrane proteins. The name of the protein and the host cell used in its recombinant production
are given. Structural images were downloaded from the PDB website (http://www.pdb.org/pdb/home/home.do) on 30th March 2015; protein
chains are coloured from the amino-terminus to the carboxy-terminus using a spectral colour gradient. (a) The structure of the KcsA potassium
channel (PDB code: 2JK5) was solved to 2.4 A˚ using a truncated protein produced in E. coli in which thirty-five residues of KcsA had been
removed with chymotrypsin. (b) The structure of the aquaporin 2 water channel was solved to 2.75 A˚ (PDB code: 4NEF) using recombinant protein
produced in P. pastoris following codon optimisation of the corresponding gene sequence. (c) The structure of the NRT1.1 nitrate transporter at
3.7 A˚ (PDB code: 4CL4) was solved using a fusion protein with carboxy-terminal GFP and hexahistidine tags that had been produced in S.
cerevisiae. (d) The structure of a voltage-gated calcium channel at 2.75 A˚ (PDB code: 4MS2) was solved after six mutant forms of the protein were
produced using the baculovirus system. (e) The 3 A˚ crystal structure of the GABAA receptor (PDB code: 4COF) was solved after approximately
one-hundred construct variants of the full-length human b3 subunit were evaluated in a mammalian cell expression system.strong polyhedrin promoter (polyhedrin mRNA accounts
for 20% of polyadenylated mRNA in the cell [23]) is likely
to produce very high levels of mRNA that overwhelm
post-transcriptional pathways; second, viral-based expres-
sion systems impair the secretory pathway of a host cell
[24], which will negatively impact on the ability of the
nascent protein to fold.
Recovering functional protein from recombinant host
cells is critically dependent upon the ability of the host
to synthesise an authentically folded protein, which in
turn depends on the proper functioning of its secretory
pathway [25]. Recombinant eukaryotic proteins are of-
ten produced in low yields or are misfolded in prokary-
otic host cells [26]. One explanation for this is that
polypeptide synthesis rates are faster in prokaryotes
(10–20 amino acids per s) than in eukaryotes (3–8 amino
acids per s) [27]. A popular strategy to mitigate this
has been to decrease culture temperature, but many
cellular functions that impact yield (e.g. transcription,www.sciencedirect.com translation, folding rates, membrane composition) are
also affected by low temperature stress [28], which
means that yield increases do not always transpire.
Experiments in E. coli cells with mutant ribosomes
(whose translation speed can be modulated) showed
that reducing polypeptide elongation rates enhanced
the folding efficiency of soluble firefly luciferase, the
cycle 3 mutant of Aequorea victoria green fluorescent
protein (GFP) and S. cerevisiae Cdc13p [27]. This sug-
gests that protein folding requires slow translation rates
in eukaryotes; in contrast, folding in bacteria is
uncoupled from protein synthesis. Notably, in these
experiments, decreasing translation rates in E. coli did
not result in endogenous protein misfolding or the
activation of a bacterial stress response [27].
Bottlenecks in translation
Translation is a highly regulated process that requires
interactions between mRNA, ribosomes and a large
number of other molecules in a complex, but optimisedCurrent Opinion in Structural Biology 2015, 32:147–155
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Table 1
Details of host cells used to produce recombinant a-helical transmembrane proteins for structures published in 2014 and 2015;
representative structures are illustrated in Figure 2
Description Host strain Promoter Protein produced (with PDB code in
parentheses)
Escherichia coli
The first choice host cell for
many recombinant protein
production experiments;
functional yields may be
low especially for
eukaryotic targets [50] and
expression is typically via
episomal plasmids that are
transiently transformed
into the host cell
BL21 (DE3) pT7lac is one of the
strongest prokaryotic
promoters [51]; induced
with isopropyl b-D-1-
thiogalactopyranoside
(IPTG)
AF2299 CDP-alcohol phosphotransferase
(4O6M), Atm1-type ABC exporter (4MRN and
4MYC), bacterial homologue of human ASBT
(4N7W), bacterial homologue of the BEST1
Ca2+-activated Cl channel (4WD7),
cytochrome b561 (4O6Y), insulin receptor
transmembrane domain (2MFR), KirBac3.1
inward-rectifier potassium channel (4LP8),
mitochondrial translocator protein (2MGY),
neurotensin receptor 1 (4BUO), PepTSo
oligopeptide-proton symporter (4TPH and
4UVM), prokaryote ligand-gated ion channel
ELIC (4TWD), semisweet transporter (4QNC),
translocator protein (4RYQ), translocator
protein (4UC1), UbiA prenyltransferase
(4TQ3),vascular endothelial growth factor
receptor 2 transmembrane dimer (2M59),
voltage-sensing domain of a voltage-
sensitive phosphatase (4G7V), YetJ pH-
sensitive calcium-leak channel (4PGR)
BL21 (DE3) DacrAB NADH transhydrogenase (4O93)
C41(DE3) [17] MgtE Mg2+ transporter (4U9L), NaVAe1p
voltage-gated sodium channel (4LTO),
vitamin K epoxide reductase (3KP9), YidC27-
266 insertase (3WO6)
C43 (DE3) [17] Pentameric ligand-gated ion channel GLIC
(4TWD), D14 sterol reductase (4QUV)
Rosetta (DE3) a7 neuronal Ach receptor (2MAW)
Novablue (DE3) pT5lac is one of the
strongest prokaryotic
promoters [51]; induced
with IPTG
KcsA potassium channel (2JK5; Figure 2a)
C43 (DE3) pBAD is typically induced
by arabinose
CmeC bacterial multi-drug efflux transporter
(4MT4), heterodimeric ABC exporter (4Q4H)
MC1061 PnuC vitamin B3 transporter (4QTN), SLC11
(NRAMP) transition-metal ion transporter
(4WGV)
TOP10 Glutamate transporter homologue (4P19 and
4X2S)
Pichia pastoris
Methylotrophic yeast noted
for its ability to grow to very
high cell densities [52];
expression is typically via
stably-integrated
expression cassettes [13]
GS115 pAOX1 is a very strong
promoter [13,33] typically
induced with methanol
P-glycoprotein (4M1M)
GS115 aqy1D Aquaporin 2 (4NEF; Figure 2b)
KM71H Leukotriene LTC4 synthase (4JCZ)
SMD1163; lacks
proteinase A (Pep4) and B
(Prb1) activity [13]
Bestrophin-1 Ca2+-activated Cl channel
(4RDQ), P-glycoprotein homologue
CmABCB1 (3WME), two-pore domain
potassium channel K2P4.1 (4WFF)
Saccharomyces cerevisiae
Yeast with a wide range of
genetic resources that
have enabled host
engineering studies [26];
expression is typically via
episomal plasmids that are
transiently transformed
into the host cell, but
stable integration is
sometimes used
FGY217; deletion of the
pep4 gene in this yeast
strain inhibits Pep4
protease activity and
reduces the levels of
other vacuolar
hydrolases [53]
pGAL1 is induced with
galactose
NRT1.1 nitrate transporter (4CL4; Figure 2c),
TMEM16 Ca2+-activated lipid scramblase
(4WIS)
Current Opinion in Structural Biology 2015, 32:147–155 www.sciencedirect.com
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Table 1 (Continued )
Description Host strain Promoter Protein produced (with PDB code in
parentheses)
Insect cells
Widely used host [54],
especially in the
production of G protein-
coupled receptors,
although functional yields
may be low [22];
expression occurs through
the generation of viral
particles that are used to
infect insect cell cultures
Spodoptera frugiperda The polyhedrin promoter
is one of the strongest
eukaryotic promoters
[23]; it is constitutive
ASIC1 acid-sensing ion channel (4NTW),
claudin-15 (4P79), GluA2 glutamate receptor
(4U4G), GluN1a/GluN2B NMDA receptor
(4EP5), GPR40 free fatty-acid receptor 1
(4PHU), Hv1 chimeric voltage-gated proton
channel (3WKV), metabotropic glutamate
receptor 1 (4OR2), metabotropic glutamate
receptor 5 (4OO9), NRT1.1 nitrate transporter
(4OH3), d-opioid receptor (4N6H), P2Y12
receptor (4NTJ and 4PXZ), g-secretase
nicastrin extracellular domain (4R12)
Trichoplusia ni GLUT1 glucose transporter (4PYP), voltage-
gated calcium channel (CaV; 4MS2;
Figure 2d)
Mammalian cell culture
An authentic host for
producing fully functional
[55] mammalian proteins
[56]; expression can be via
transient transfection or
stable integration
HEK293S GnTI; N-
acetylglucosaminyl
transferase I-negative
cells that are unable to
synthesise complex N-
glycans [57]; gene
transduction of
mammalian cells was
baculovirus-mediated
The cytomegalovirus
(CMV) promoter is strong
in this host cell [58] and is
constitutive
GluA2 glutamate receptor (4U2P and 4U5B),
GluN1a/GluN2B NMDA receptor (4TLL)
HEK293F Chick actin promoter with
a CMV enhancer [59]
g-Secretase nicastrin extracellular domain
(4UPC)
HEK293T GABAA receptor (4COF; Figure 2e)
T-REx-293 (a stable cell-
line was generated)
CMV promoter Serotonin 5-HT3 receptor (4PIR)network that has been well-described for prokaryotes
[29] and eukaryotes [30]. In eukaryotic cells, a key player
in translational regulation is the mammalian target of
rapamycin (mTOR) complex, which controls ribosome
and tRNA biogenesis, translation initiation and entry into
quiescence (G0 phase) [31]; mTOR is a central regulator
of cell metabolism, growth, proliferation and survival,
demonstrating the essential link between translation and
host cell physiology.
The translational machinery of a cell responds to its
growth rate, which is strongly affected by nutrient avail-
ability. Changes in nutrient source were recently shown
to significantly reprogramme the transcriptome of P.
pastoris under growth conditions relevant to recombi-
nant protein production [32]. The main response was
found to be transcriptional, while translational regula-
tion was global rather than transcript-specific. When P.
pastoris cells were cultured in methanol, a high propor-
tion of the mRNA pool was associated with two or more
ribosomes (and therefore deemed to be highly translat-
ed); methanol is typically used to induce protein pro-
duction in this yeast species, which suggests that high
recombinant protein yields may be associated with the
slow growth rate observed under these conditions as well
as promoter activity [33]. It has been known for decadeswww.sciencedirect.com that ribosomes from slow-growing cells have lower ami-
no acid incorporation rates per second per ribosome than
cells that are growing normally [34]. Slowing transla-
tion speed may therefore enhance recombinant protein
folding efficiency.  In support of this, partial inhibition of
translation in mammalian host cells (using the drug,
emetine) was shown to result in a substantial reduction
in the yield of misfolded Pontellina plumata GFP; eme-
tine treatment also increased the functional recombinant
yields of both GFP and a DF508 mutant of the cystic
fibrosis transmembrane conductance regulator [35].
Lower translation speed has been postulated to directly
lead to higher translational accuracy [36]. This is difficult
to reconcile with current biochemical knowledge of
translation but if the relationship does indeed exist,
slower translation could be beneficial for the production
of difficult-to-fold proteins that are particularly sensitive
to translational errors.
The sequence of the mRNA transcript is also impor-
tant in determining the rate and accuracy of protein
translation [37]. It is established that individual species
have a preference for certain of the 64 available codons
over others, but the biological reason for this is unclear.
One idea is that each codon has a different decoding
time; ‘faster’ codons lead to a higher translation rate,Current Opinion in Structural Biology 2015, 32:147–155
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Insights into the workings of a recombinant host cell factory. A host–cell-centric approach to producing recombinant proteins for structural
analysis focuses on maximising the functional yield of every cell; in this case, the philosophy is to understand the workings of the ‘cell factory’
shown in Figure 1. Any recombinant host cell must simultaneously balance its requirements for cellular growth with the metabolic burden imposed
by the expression plasmid, where transcription is typically under the control of a strong promoter (see Table 1) although this may be countered by
high rates of mRNA degradation. Factors affecting the successful production of a recombinant protein include the availability of energy (in the
form of ATP and/or GTP), tRNAs, ribosomes, mRNA structure, the integrity of the folding and secretory pathways and cell stress responses. For
membrane proteins, translation and protein folding are critical parameters; their modulation may help to further improve host cells.which is more resource efficient [38]. Recently, ‘speed
control signals’ have been proposed in the signal pep-
tides of secreted proteins that delay translation to allow
co-translational and post-translational translocation,
protein processing and folding [39]. Codon usage bias
was found be normal in open reading frames, but
decreased in signal peptide coding regions [39]. This
may have consequences for the optimal design of the
heterologous DNA construct in Figures 1 and 3. An-
other idea is that different codons are read with dif-
ferent degrees of accuracy: when translational accuracy
was included as a parameter in the design of expression
constructs for a Plasmodium lysyl-tRNA synthetase inCurrent Opinion in Structural Biology 2015, 32:147–155 E. coli, proteolysis was reduced and solubility in-
creased [40].
Bottlenecks in folding and secretion
Translation, folding and secretion are interconnected
pathways that draw on the same cellular resources. If
the interconnections are not optimised in favour of the
recombinant protein, then yields will be low (Figure 3).
Most nascent proteins do not fold spontaneously in vivo,
but require a network of chaperones that not only facili-
tate protein folding, but also perform quality control,
ensuring that damaged or misfolded proteins are degrad-
ed or refolded. Many studies have focused on thewww.sciencedirect.com
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ones to improve recombinant protein yields [41], but a
current trend is to exploit a host cell’s global stress
response to misfolded proteins to ensure the proper
functioning of its secretory pathways; this approach is
anticipated to be more effective in improving the quan-
tity and quality of recombinant protein for structural
studies [42]. In eukaryotes, even moderate levels of
stress cause a decrease in the rate of translation, the
sequestering of mRNA into stress granules and the
aggregation of proteins [43]. It still remains unclear
how cells regulate this response, but the ability to influ-
ence the distribution of diverse chaperones in vivo may
offer solutions to improving protein yields [44]. For
example, a recent study of recombinant G protein-cou-
pled receptor production in S. cerevisiae demonstrated
that mislocalised proteins were associated with the en-
doplasmic reticulum chaperone, BiP [45].
The impact of two cellular responses is of particular
interest: The unfolded protein response (UPR; influenc-
ing the early part of the secretory pathway) and the heat
shock response (HSR; a response to cytosolic stress).
Recombinant protein production is likely to affect ER
homeostasis and therefore trigger a UPR, which in turn
causes an increase in the folding capacity of a cell [25];
recently biosensors have been used to measure the UPR
in mammalian cell-lines producing monoclonal antibo-
dies [46]. During the UPR in yeast, about 5% of the
genome is up-regulated (mirroring the situation in higher
eukaryotes), ribosomal biogenesis and assembly are trans-
lationally repressed and mRNAs encoding the UPR tran-
scription factor Hac1p, the ER-oxidoreductase Ero1p and
the ER-associated protein degradation (ERAD) protein
Der1p, are enriched in polysomal fractions, indicating
translational up-regulation [47]. The HSR activates cha-
perones and the proteasome in order to relieve stress.
HSR up-regulation has been used to increase recombi-
nant yields of soluble a-amylase in S. cerevisiae, but did
not increase the yield of a recombinant human insulin
precursor [48]. It is now established that the UPR, HSR
and other stress responses (such as the environmental
stress response; ESR) overlap with each other, providing a
hormetic benefit to cells in which mild stress enhances
tolerance to future stressful stimuli [49] such as that
imposed during recombinant protein production.
Conclusions
The use of stabilising mutations to improve the crystal-
lisation propensity of recombinant membrane proteins
has resulted in major breakthroughs in modern structural
biology [3]. Our emerging understanding of how the
processes of translation and protein folding are affected
in recombinant host cells now offers new, complementary
opportunities to improve functional yields. However, the
interlinked nature of transcription, translation, folding
and secretion and their impact on cell physiology meanswww.sciencedirect.com that optimising host cells to be maximally productive with
respect to functional recombinant protein yield is both
intellectually and technically demanding. Table 1 sug-
gests a dominant role for microbial host cells in membrane
protein structural biology projects; since microbes are
particularly amenable to genetic engineering, new insight
may emerge from their use in the foreseeable future.
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